Kotak’s PIPE fund bets on Mumbai-based pharma firm

Premium

Kotak Private Equity, the alternative asset investment arm of India’s fourth-largest private lender Kotak Mahindra Bank, has picked a stake in a pharmaceuticals company that manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India.The India Whizdom Fund, which started investing in last April, has picked a small stake, ......